Presentation Trends in Hospitalization and Outcomes for Acute CVD and Stroke, 1999-2011 Presenter: Harlan M. Krumholz August 29, 2014
News Industry News Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia July 30, 2014
News Daily News Leaders from NIH, FDA, Academia Urge US Government to Invest in Medical Innovation L.A. McKeown May 09, 2014
News Industry News Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in Europe May 01, 2014
News Industry News Takeda Presents Additional Data from the EXAMINE Cardiovascular Safety Outcomes Trial at the American College of Cardiology's 63rd Annual Scientific Session March 27, 2014
News Conference News TCT 2013 Innovation in Intervention: Perspectives from Industry October 30, 2013
News Conference News TCT 2013 State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors October 29, 2013
News Daily News ESC Position Paper Offers Guidance on Dual PPI and Antithrombotic Use Caitlin E. Cox February 27, 2013
News Daily News Improved Homing of Cardiac Stem Cells Shows Promise for Cardiomyopathy February 21, 2013
News Daily News El Tropismo Mejorado de las Células Madre Cardíacas contra la Cardiomiopatía resulta Prometedor February 21, 2013
News Daily News Italian Generic Clopidogrel Worse Than Brand Name at Suppressing Platelets Jason Kahn December 13, 2012
News Daily News El Genérico Italiano Clopidogrel es Peor que la Marca Comercial en la Supresión Plaquetaria Jason Kahn December 13, 2012
News Conference News TCT 2012 TRILOGY ACS Substudy: Angiography Prior to Prasugrel Therapy Reduces CV Events October 25, 2012
News Daily News Polyvascular Disease Worsens Long-term Prognosis for Older NSTEMI Patients July 03, 2012
News Conference News ACC 2012 Benefits of Transradial PCI May be Limited to High Volume Centers Jason Kahn March 27, 2012
News Conference News Coronary Heart Disease Mortality Down, But Prevention Efforts Still Needed November 08, 2011
News Industry News Resverlogix Expands Phase 2b Program with the Commencement of Dosing in SUSTAIN September 27, 2011
News Daily News Low US Participation in NIH-Sponsored CVD Trials Cause for Concern Jason Kahn August 01, 2011